scPharmaceuticals Inc.
scPharmaceuticals Inc. (SCPH): 10 pipeline candidates · ~10 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
9.7 months
D/E -4.76 · 1% dilution
Lead: Phase 1
10 candidates
N/A
N/A
A transparent, data-derived signal for scPharmaceuticals Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$40.8M
Quarterly Burn
$16.1M
Runway
9.7 mo
Revenue
$16.0M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (10 candidates)
Frequently asked questions
How many drug candidates are in scPharmaceuticals Inc.'s pipeline?
scPharmaceuticals Inc. (SCPH) has 10 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is scPharmaceuticals Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, scPharmaceuticals Inc. has approximately 9.7 months of cash runway.
Who is the CEO of scPharmaceuticals Inc.?
Important Notice Regarding is the chief executive officer of scPharmaceuticals Inc. (SCPH).
Get the full picture on scPharmaceuticals Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.